Skandinaviska Enskilda Banken (SEB)
KYMR icon

Skandinaviska Enskilda Banken (SEB)’s Kymera Therapeutics KYMR Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-38,141
Closed -$1.66M – 848
2025
Q2 		$1.66M Hold
38,141
– – 0.01% 598
2025
Q1 		$1.04M Hold
38,141
– – 0.01% 633
2024
Q4 		$1.5M Hold
38,141
– – 0.01% 615
2024
Q3 		$1.81M Hold
38,141
– – 0.01% 604
2024
Q2 		$1.14M Hold
38,141
– – 0.01% 629
2024
Q1 		$1.53M Buy
+38,141
New +$1.36M 0.01% 618

Other funds holding KYMR

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s KYMR Position: Q3 2025 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Kymera Therapeutics (KYMR) in Q3 2025, closing a stake of 38,141 shares — an estimated $1.66M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in KYMR in Q1 2024 and held it in 6 quarters. The position peaked at $1.81M in Q3 2024. 210 funds tracked by Wall St. Rank hold KYMR as of Q3 2025.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Kymera Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 38,141 Kymera Therapeutics shares in Q3 2025, an estimated $1.66M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Kymera Therapeutics in Q1 2024 and held it in 6 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Kymera Therapeutics position peaked at $1.81M in Q3 2024.
  • 210 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q3 2025.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2025, filed 7 Nov 2025.